Because inhibition of ESM1 could enhance the abilities of proliferation, migration and invasion of prostate cancer cells in vitro, it was necessary to examine whether this effect could enhance the progression of prostate cancer cells in vivo. Here, ESM1 is linked to prostate cancer.